Which peptides the FDA is approving, reviewing, or restricting - reported as regulatory facts, updated daily. No hype, no usage advice, just what the agency actually did.
Ares Research on Peptide Stores Online: 219 active listings across over 100 different compounds, one of the deepest catalogs on the marketplace, with a full metabolic range led by Tirzepatide, Retatrutide, and Semaglutide.
Read the full regulatory breakdown →Peptuvia on Peptide Stores Online: 107 active listings across 100 distinct compound groups, an inventive blend range, and verified public certificates of analysis linked from 9 product pages.
American Peptides on Peptide Stores Online: 68 active listings, verified public certificates of analysis linked from 63 product pages, a published 3.1 out of 5 ratings score, and a 78 percent Finnrick rating.
Alpha Pro Peptides on Peptide Stores Online: 64 active listings, verified public certificates of analysis linked from 43 product pages, and capsule, spray, and serum formats alongside vials.
Neuro Labs on Peptide Stores Online: 63 active listings across 48 compound groups, a distinctive Mist spray range, and 20 percent off a first order with code PEPTIDESTOREONLINECOM.
Offline Peptides on Peptide Stores Online: 60 active listings across 42 compound groups, from Cagrilintide and MOTS-c to the OP-2 (TZ) and OP-3 (RT) ranges in multiple sizes, with a 10 percent shopper discount detailed inside.
Peptide Maxxing on Peptide Stores Online: 57 active listings across 46 compound groups, from the TZ Series and RT Series to Tesamorelin and MOTS-C, plus ready-made solutions and a 15 percent shopper discount detailed inside.
MsAmino on Peptide Stores Online: 53 active listings across 53 compound groups, standout format variety from capsules to research mists, and verified public certificates of analysis linked from 28 of its product pages.
Sparta Labs on Peptide Stores Online: 49 active listings across 37 compound groups, led by the GLP-1 (SG), GLP-2 (TZ), and GLP-3 (RT) range plus Cagrilintide, Tesamorelin, and MOTS-c.
GenX Peptides on Peptide Stores Online: 48 active listings across 48 compound groups, every listing a different compound or blend, from spelled-out Semaglutide to the coded GP-2-TIRZ and GP-3 RETA ranges.
Voltera Sciences on Peptide Stores Online: 47 active listings across 31 compound groups, with the VLS-2TRZ and VLS-3RT ranges each running to four sizes plus Tesamorelin, MOTS-c, and AOD-9604.
Amino Labs on Peptide Stores Online: 46 active listings across 42 compound groups, a smart 3-pack format across the range, and verified public certificates of analysis linked from 6 product pages.
Vertex Labs on Peptide Stores Online: 44 active listings across 29 compound groups, verified public certificates of analysis linked from 35 product pages, and 10 percent off with a shopper code.
Sera Peptides on Peptide Stores Online: 42 active listings across 26 compound groups, a focused metabolic and classic research range, and 20 percent off with a shopper code.
Peptide.Express on Peptide Stores Online: 42 active listings across 26 compound groups, a six-size Retatrutide range, and verified public certificates of analysis linked from 20 product pages.
Aura Research on Peptide Stores Online: 40 active listings across 40 compound groups, with single vials and 10-vial kits side by side across the whole range.
True Peptides on Peptide Stores Online: 39 active listings across 23 compound groups, a deep Retatrutide range in spelled-out and GLP 3 RT listings, and 10 percent off with a shopper code.
DelixLabs on Peptide Stores Online: 38 active listings across 31 compound groups, a sharp metabolic range led by Semaglutide and Cagrilintide plus smart research bundles, and 10 percent off with a reader code.
Giga Compounds on Peptide Stores Online: 33 active listings across 25 compound groups, verified public certificates of analysis linked from 27 product pages, and 10 percent off a first order.
V8 Peptides on Peptide Stores Online: 31 active listings across 26 compound groups, a full named metabolic range with Tirzepatide, Retatrutide, and Semaglutide, verified COAs on 12 product pages, and 10 percent off with a reader code.
Alera Research on Peptide Stores Online: 25 active listings across 23 compound groups, a clean metabolic-led range built around its GLP-1S, GLP-2T, and GLP-3R lines, and 10 percent off with a reader code.
Healio Peptides on Peptide Stores Online: 24 active listings across 17 compound groups, a focused range where Tirzepatide and Retatrutide each come in three sizes and every listing earns its place.
AminoVault on Peptide Stores Online: 15 active listings, one for each of 15 distinct compounds, verified public certificates of analysis linked from 8 product pages, and 15 percent off with a reader code.
Simms Research on Peptide Stores Online: 39 active listings across 22 single compounds plus blends, published lot certificates of analysis from Freedom Diagnostics Testing, and an honest Not Yet Rated ratings status explained.
LabFirst Peptides on Peptide Stores Online: 124 active listings, verified public certificates of analysis linked from 44 product pages, and 10 percent off with code PSOL10.
HPLC purity versus net peptide content: what the two numbers on a peptide certificate of analysis mean, how each is measured, why they use different denominators, and how to compare them fairly across vendors.
How to compare research peptide vendors: a buyer's checklist covering lot-matched certificates of analysis, testing evidence, delivered price, catalog depth, track record, and the red flags that end a comparison early.
Lyophilized peptide storage explained: what published research and vendor data sheets say about temperature, moisture, light, shelf life, and how to read the storage line on a listing or certificate of analysis before you buy.
How to check peptide lab results and COAs for free with Finnrick: look up published HPLC results for identity, purity, and quantity by product and vendor, read the full test detail behind a result, and use free community testing for eligible sealed samples.
Third-party peptide testing explained: what independent labs actually check, including identity by mass spectrometry, purity by HPLC, quantity and net content, how third-party testing differs from in-house testing, and how to verify a lab report.
Learn how to read a peptide certificate of analysis: identity testing with HPLC and mass spectrometry, purity percentages, batch and lot numbers, test dates, the testing laboratory, third-party vs in-house testing, and the red flags that make a COA worthless.
Bristol Myers Squibb and RayzeBio reported on October 12, 2026 that RYZ101 (225Ac-DOTATATE), an investigational peptide radiopharmaceutical, met the primary progression-free survival endpoint at the planned interim analysis of the Phase 3 ACTION-1 trial in somatostatin receptor-positive GEP-NETs. The candidate is not FDA approved, and the sponsor said it plans to engage the FDA toward a regulatory submission.
Boehringer Ingelheim reported that the investigational glucagon/GLP-1 dual agonist survodutide met both co-primary endpoints in the Phase 3 SYNCHRONIZE-2 trial in adults with overweight or obesity and type 2 diabetes. Full results were presented October 1, 2026 at EASD and published in the New England Journal of Medicine.
On August 28, 2026, the FDA approved MIMRYLO (rusfertide), a first-in-class hepcidin mimetic peptide for erythrocytosis in adults with polycythemia vera - the first hepcidin mimetic ever approved.
On July 23-24, 2026, the FDA’s Pharmacy Compounding Advisory Committee voted to recommend six peptides - BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon - for the 503A bulk drug substances list, over the objection of FDA staff scientists.
In April 2026, the FDA formally moved 12 peptides from its Category 2 bulk substances list - the tier flagged for safety concerns - reopening the regulatory path toward compounding eligibility.
On April 1, 2026, the FDA approved Foundayo (orforglipron), the first oral small-molecule GLP-1 receptor agonist for weight management in adults with obesity or overweight with a weight-related condition.
On December 22, 2025, the FDA approved the Wegovy pill (oral semaglutide 25 mg), the first once-daily oral GLP-1 peptide medicine for obesity in the United States.
Every post reports what the FDA actually did - approvals, advisory votes, reclassifications - tied to the specific drug product and indication. We never publish dosing, administration guidance, or usage advice. FDA approval belongs to a labeled product, never to a molecule in general or to compounded or research-grade material.
All products listed on Peptide Stores Online are for in-vitro laboratory and educational research purposes only. Not for human or animal consumption. Not evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease or condition. All sellers and buyers agree to full research-use-only terms at account creation. Peptide Stores Online assumes no liability for misuse of any product listed on this platform.